Vosaroxin: a novel antineoplastic quinolone
作者： Jonathan A Abbas , Robert K Stuart
DOI: 10.1517/13543784.2012.699038
关键词: Acute leukemia 、 Vosaroxin 、 Younger age 、 Oncology 、 American population 、 Pharmacology 、 Clinical trial 、 Myeloid leukemia 、 Quinolone 、 Medicine 、 Prognostic prediction 、 Internal medicine 、 Pharmacology (medical) 、 General Medicine
摘要: … The aim of this review is to summarize the development and preclinical and clinical data on vosaroxin, with an emphasis on its therapeutic advantages and future clinical utilization of …
informahealthcare.com参考文章(58)
G Del Poeta, R Stasi, G Aronica, A Venditti, MC Cox, A Bruno, F Buccisano, M Masi, M Tribalto, S Amadori, G Papa, Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood. ,vol. 87, pp. 1997- 2004 ,(1996) , 10.1182/BLOOD.V87.5.1997.1997
P Fenaux, P Jonveaux, I Quiquandon, JL Lai, JM Pignon, MH Loucheux-Lefebvre, F Bauters, R Berger, JP Kerckaert, P53 Gene Mutations in Acute Myeloid Leukemia With 17p Monosomy Blood. ,vol. 78, pp. 1652- 1657 ,(1991) , 10.1182/BLOOD.V78.7.1652.1652
E Wattel, C Preudhomme, B Hecquet, M Vanrumbeke, B Quesnel, I Dervite, P Morel, P Fenaux, p53 Mutations Are Associated With Resistance to Chemotherapy and Short Survival in Hematologic Malignancies Blood. ,vol. 84, pp. 3148- 3157 ,(1994) , 10.1182/BLOOD.V84.9.3148.3148
List Af, Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia Leukemia. ,vol. 10, pp. 937- 942 ,(1996)
J Yates, O Glidewell, P Wiernik, MR Cooper, D Steinberg, H Dosik, R Levy, C Hoagland, P Henry, A Gottlieb, C Cornell, J Berenberg, JL Hutchison, P Raich, N Nissen, RR Ellison, R Frelick, GW James, G Falkson, RT Silver, F Haurani, M Green, E Henderson, L Leone, JF Holland, Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study Blood. ,vol. 60, pp. 454- 462 ,(1982) , 10.1182/BLOOD.V60.2.454.454
Grace L Chen, Liu Yang, TC Rowe, Brian D Halligan, Kathleen M Tewey, Leroy F Liu, Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. Journal of Biological Chemistry. ,vol. 259, pp. 13560- 13566 ,(1984) , 10.1016/S0021-9258(17)47282-6
P G Rose, J A Blessing, A R Mayer, H D Homesley, Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. Journal of Clinical Oncology. ,vol. 16, pp. 405- 410 ,(1998) , 10.1200/JCO.1998.16.2.405
M.J. Robinson, B.A. Martin, T.D. Gootz, P.R. McGuirk, M. Moynihan, J.A. Sutcliffe, N. Osheroff, Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage. Journal of Biological Chemistry. ,vol. 266, pp. 14585- 14592 ,(1991) , 10.1016/S0021-9258(18)98726-0
L F Liu, T C Rowe, L Yang, K M Tewey, G L Chen, Cleavage of DNA by mammalian DNA topoisomerase II. Journal of Biological Chemistry. ,vol. 258, pp. 15365- 15370 ,(1983) , 10.1016/S0021-9258(17)43815-4
Tetsuo OKADA, Kiyoshi EZUMI, Masumi YAMAKAWA, Hisao SATO, Teruji TSUJI, Tadahiko TSUSHIMA, Kiyoshi MOTOKAWA, Yoshihide KOMATSU, Quantitative Structure-Activity Relationships of Antibacterial Agents, 7-Heterocyclic Amine Substituted 1-Cyclopropyl-6,8-difluoro-4-oxoquinoline-3-carboxylic Acids. Chemical & Pharmaceutical Bulletin. ,vol. 41, pp. 126- 131 ,(1993) , 10.1248/CPB.41.126